SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-07-087127
Filing Date
2007-12-05
Accepted
2007-12-05 16:09:21
Documents
11
Period of Report
2007-12-05
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a07-30730_18k.htm 8-K 29185
2 EX-99.1 a07-30730_1ex99d1.htm EX-99.1 19741
3 EX-99.2 a07-30730_1ex99d2.htm EX-99.2 14036
4 GRAPHIC g307301moi001.jpg GRAPHIC 43666
5 GRAPHIC g307301moi002.jpg GRAPHIC 156827
6 GRAPHIC g307301moi003.jpg GRAPHIC 66216
7 GRAPHIC g307301moi004.jpg GRAPHIC 64322
8 GRAPHIC g307301moi005.jpg GRAPHIC 49521
9 GRAPHIC g307301moi006.jpg GRAPHIC 36469
10 GRAPHIC g307301moi007.jpg GRAPHIC 37370
11 GRAPHIC g307301moi008.jpg GRAPHIC 33240
  Complete submission text file 0001104659-07-087127.txt   737587
Mailing Address 901 GATEWAY BLVD S. SAN FRANCISCO CA 94080
Business Address 901 GATEWAY BLVD SOUTH SAN FRANCISCO CA 94080 6508086000
THERAVANCE INC (Filer) CIK: 0001080014 (see all company filings)

IRS No.: 943265960 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-30319 | Film No.: 071286820
SIC: 2834 Pharmaceutical Preparations